Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides. 2016

Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
School of Perfume and Aroma Technology, Shanghai Institute of Technology, Shanghai 201418, China. szliuhm@sit.edu.cn.

Four series of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives 11a-j, 12a-j, 13a-g and 14a-g bearing phenylpyridine/phenylpyrimidine- carboxamide scaffolds were designed, synthesized and their IC50 values against three cancer cell lines (A549, PC-3 and MCF-7) were evaluated. Eleven of the compounds showed moderate cytotoxicity activity against the cancer cell lines. Structure-activity relationships (SARs) and pharmacological results indicated that the introduction of phenylpyridine-carboxamide scaffold was beneficial for the activity. What's more, the oxidation of the sulfur atom in thiopyran and various types of substituents on the aryl group have different impacts on different series of compounds. Furthermore, the positions of aryl group substituents have a slight impact on the activity of the phenylpyridine-carboxamide series compounds.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D061986 MCF-7 Cells An estrogen responsive cell line derived from a patient with metastatic human breast ADENOCARCINOMA (at the Michigan Cancer Foundation.) MCF7 Cells,Michigan Cancer Foundation 7 Cells,Cell, MCF-7,Cell, MCF7,Cells, MCF-7,Cells, MCF7,MCF 7 Cells,MCF-7 Cell,MCF7 Cell

Related Publications

Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
August 2016, Bioorganic & medicinal chemistry,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
October 2017, Molecules (Basel, Switzerland),
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
December 2014, Bioorganic & medicinal chemistry,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
June 2016, European journal of medicinal chemistry,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
February 2017, Molecules (Basel, Switzerland),
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
September 2018, Archiv der Pharmazie,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
October 1986, Chemical & pharmaceutical bulletin,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
February 2014, Bioorganic & medicinal chemistry letters,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
September 2013, European journal of medicinal chemistry,
Huimin Liu, and Wenhui Wang, and Chengyu Sun, and Caolin Wang, and Wufu Zhu, and Pengwu Zheng
January 2015, Molecules (Basel, Switzerland),
Copied contents to your clipboard!